Korean Journal of Veterinary Research (대한수의학회지)

The Korean Society of Veterinary Science (대한수의학회)
권호 표지
DOI QR코드

DOI QR Code

Assessment of prognostic factors in dogs with mammary gland tumors: 60 cases (2014-2020)

  • Moon, Chang-Hwan (Department of Veterinary Surgery, College of Veterinary Medicine, Chungnam National University) ;
  • Kim, Dae-Hyun (Department of Veterinary Surgery, College of Veterinary Medicine, Chungnam National University) ;
  • Yun, Sung-Ho (Department of Veterinary Surgery, College of Veterinary Medicine, Kyungpook National University) ;
  • Lee, Hae-Beom (Department of Veterinary Surgery, College of Veterinary Medicine, Chungnam National University) ;
  • Jeong, Seong-Mok (Department of Veterinary Surgery, College of Veterinary Medicine, Chungnam National University)
  • Received : 2021.11.10
  • Accepted : 2022.01.04
  • Published : 2022.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Canine mammary gland tumors are the most common neoplasms in intact female dogs. Approximately half of all mammary tumors are malignant, and there is a risk of metastasis, which is associated with a poor prognosis. This study was to evaluate the prognostic factors of canine mammary gland tumors and the risk factors associated with the development of malignant tumors. From 2014 to 2020, 60 dogs with mammary gland tumors that underwent surgical treatment were evaluated in this retrospective study. Tumor size, TNM stage, and histopathological results were prognostic factors for 2-year survival after surgery. Every 10 mm increase in tumor size, increased the risk of death within 2 years after surgery 1.213 times. Dogs with TNM stage IV or V had 8.667 fold risk of death within 2 years after surgery. The 2-year survival rate for dogs with benign tumors was 90.2% and for malignant tumors was 67.3%. Tumor size is the most important prognostic factor for canine mammary gland tumors. As tumor size increased by 10 mm, the risk for development of malignant tumors increased by 1.487 times. Tumors larger than 30 mm are highly likely to be malignant, and metastatic evaluation and wide resection should be considered.

Keywords

Acknowledgement

This work was supported by a research fund from the Chungnam National University.

References

  1. Sleeckx N, de Rooster H, Veldhuis Kroeze EJ, Van Ginneken C, Van Brantegem L. Canine mammary tumours, an overview. Reprod Domest Anim 2011;46:1112-1131. https://doi.org/10.1111/j.1439-0531.2011.01816.x
  2. Dorn CR, Taylor DO, Schneider R, Hibbard HH, Klauber MR. Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. J Natl Cancer Inst 1968;40:307-318.
  3. MacEwen EG, Vail DM, Page RL. Withrow & MacEwen's Small Animal Clinical Oncology. 5th ed. pp. 356-372, Elsevier Saunders, St. Louis, 2013.
  4. Meuten DJ. Tumors in Domestic Animals. 4th ed. pp. 576- 606, Iowa State University Press, Ames, 2002.
  5. Fossum TW. Small Animal Surgery. 4th ed. pp. 809-815, Elsevier Saunders, St. Louis, 2013.
  6. Misdorp W, Hart AA. Canine mammary cancer. II. Therapy and causes of death. J Small Anim Pract 1979;20:395-404. https://doi.org/10.1111/j.1748-5827.1979.tb06744.x
  7. Straw R. Treatment of Mammary Gland Tumours and Perianal Neoplasia. pp. 672-675, North American Veterinary Conference, Orlando, 2005.
  8. Hellmen E, Bergstrom R, Holmberg L, Spangberg IB, Hansson K, Lindgren A. Prognostic factors in canine mammary tumors: a multivariate study of 202 consecutive cases. Vet Pathol 1993;30:20-27. https://doi.org/10.1177/030098589303000103
  9. Brodey RS, Fidler IJ, Howson AE. The relationship of estrous irregularity, pseudopregnancy, and pregnancy to the development of canine mammary neoplasms. J Am Vet Med Assoc 1966;149:1047-1049.
  10. Misdorp W. Canine mammary tumours: protective effect of late ovariectomy and stimulating effect of progestins. Vet Q 1988;10:26-33. https://doi.org/10.1080/01652176.1988.9694142
  11. Schneider R, Dorn CR, Taylor DO. Factors influencing canine mammary cancer development and postsurgical survival. J Natl Cancer Inst 1969;43:1249-1261.
  12. Sorenmo KU, Shofer FS, Goldschmidt MH. Effect of spaying and timing of spaying on survival of dogs with mammary carcinoma. J Vet Intern Med 2000;14:266-270. https://doi.org/10.1892/0891-6640(2000)014<0266:EOSATO>2.3.CO;2
  13. Perez Alenza MD, Pena L, Nieto AI, Castano M. Clinical and pathological prognostic factors in canine mammary tumors. Ann Ist Super Sanita 1997;33:581-585.
  14. Ferreira E, Bertagnolli AC, Cavalcanti MF, Schmitt FC, Cassali GD. The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours. Vet Comp Oncol 2009;7:230-235. https://doi.org/10.1111/j.1476-5829.2009.00193.x
  15. Philibert JC, Snyder PW, Glickman N, Glickman LT, Knapp DW, Waters DJ. Influence of host factors on survival in dogs with malignant mammary gland tumors. J Vet Intern Med 2003;17:102-106. https://doi.org/10.1892/0891-6640(2003)017<0102:IOHFOS>2.3.CO;2
  16. Yamagami T, Kobayashi T, Takahashi K, Sugiyama M. Prognosis for canine malignant mammary tumors based on TNM and histologic classification. J Vet Med Sci 1996;58:1079-1083. https://doi.org/10.1292/jvms.58.11_1079
  17. Chang SC, Chang CC, Chang TJ, Wong ML. Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998-2002). J Am Vet Med Assoc 2005;227:1625-1629. https://doi.org/10.2460/javma.2005.227.1625
  18. Sorenmo K. Canine mammary gland tumors. Vet Clin North Am Small Anim Pract 2003;33:573-596. https://doi.org/10.1016/S0195-5616(03)00020-2
  19. Millanta F, Calandrella M, Bari G, Niccolini M, Vannozzi I, Poli A. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Res Vet Sci 2005;79:225-232. https://doi.org/10.1016/j.rvsc.2005.02.002
  20. Sorenmo KU, Kristiansen VM, Cofone MA, Shofer FS, Breen AM, Langeland M, Mongil CM, Grondahl AM, Teige J, Goldschmidt MH. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence. Vet Comp Oncol 2009;7:162-172. https://doi.org/10.1111/j.1476-5829.2009.00184.x
  21. Owen LN, World Health Organization. TNM Classification of Tumours in Domestic Animals. World Health Organization, Geneva, 1980.
  22. MacEwen EG, Harvey HJ, Patnaik AK, Mooney S, Hayes A, Kurzman I, Hardy WD Jr. Evaluation of effects of levamisole and surgery on canine mammary cancer. J Biol Response Mod 1985;4:418-426.
  23. Stratmann N, Failing K, Richter A, Wehrend A. Mammary tumor recurrence in bitches after regional mastectomy. Vet Surg 2008;37:82-86. https://doi.org/10.1111/j.1532-950X.2007.00351.x